Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a fixed-dose combination pediatric medication containing acetaminophen (paracetamol), chlorphenamine maleate, and artificial bezoar. It is primarily used to relieve symptoms associated with the common cold and influenza in children, such as fever, headache, myalgia, sneezing, rhinorrhea, nasal congestion, and sore throat. - **Acetaminophen** acts as an analgesic and antipyretic by inhibiting prostaglandin synthesis in the central nervous system. - **Chlorphenamine maleate** is a first-generation antihistamine that antagonizes histamine H1 receptors to reduce allergic symptoms like sneezing and runny nose. - **Artificial bezoar** (artificial Calculus Bovis) is included for its traditional use in Chinese medicine for its purported anti-inflammatory and detoxifying effects; it contains bilirubin as an active component[1][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + chlorphenamine + artificial bezoar.